# Multicenter Trial Investigating Performance and Safety of the Medical Device SiPore21®

> **NCT06087822** · NA · COMPLETED · sponsor: **Sigrid Therapeutics AB** · enrollment: 318 (actual)

## Conditions studied

- Overweight or Obesity

## Interventions

- **DEVICE:** IMD SiPore21®

## Key facts

- **NCT ID:** NCT06087822
- **Lead sponsor:** Sigrid Therapeutics AB
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-10-05
- **Primary completion:** 2024-07-30
- **Final completion:** 2024-07-30
- **Target enrollment:** 318 (ACTUAL)
- **Last updated:** 2024-12-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06087822

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06087822, "Multicenter Trial Investigating Performance and Safety of the Medical Device SiPore21®". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06087822. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*